PUBLISHER: Grand View Research | PRODUCT CODE: 1842256
PUBLISHER: Grand View Research | PRODUCT CODE: 1842256
The U.S. equine artificial insemination market size was estimated at USD 155.44 million in 2024 and is projected to reach USD 247.83 million by 2033, growing at a CAGR of 5.41% from 2025 to 2033. The market is continuously growing, driven by the rising popularity of performance and recreational horses, expanding equine veterinary infrastructure, and a supportive regulatory and breeding industry ecosystem. The professional racing and competition, the growing popularity of recreational riding, show jumping, and Western performance events, are driving demand for high-quality horses in the U.S. The U.S. is home to around 9.2 million horses, playing a vital role in recreation, competition, and the broader equine industry. Among this population, nearly 3.9 million are engaged in recreational activities, while about 2.7 million participate in horse shows, reflecting the strong cultural and economic importance of equestrian pursuits nationwide.
Owners are increasingly investing in artificial insemination (AI) to secure foals with superior genetics for endurance, agility, and temperament. This demand spans disciplines such as rodeo, barrel racing, hunter/jumper circuits, and dressage. By enabling wider access to proven stallions, AI supports the breeding of horses suited to diverse performance needs. The expanding recreational equine sector, particularly in states like Texas, Kentucky, and California, continues to boost AI adoption.
U.S. Equine Artificial Insemination Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. equine artificial insemination market report based on solution, equine, and distribution channel: